Clinical Trial

Insulin Resistance and Its Association With no Reflow Phenomenon After Primary PCI in Type II Diabetic STEMI Patients.

Name: Insulin Resistance and Its Association With no Reflow Phenomenon After Primary PCI in Type II Diabetic STEMI Patients. — clinical trial record (NCT07706335)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

To investigate the relationship between the TyG index, coronary lesion complexity assessed by the SYNTAX score, and the development of the no-reflow phenomenon in STEMI patients with T2DM.

Protocol Amendment History 1 change

critical Primary endpoint(s) modified 2026-07-17

Trial Details

NCT Number	NCT07706335
Lead Sponsor	Assiut University
Conditions	STEMI, No-Reflow Phenomenon, Diabetic Patient
Enrollment	100 participants
Start Date	2026-08-01
Primary Completion	2028-08-01 (estimated)
Study Completion	2029-08-01 (estimated)
Updated on ClinicalTrials.gov	2026-07-16